Structure |
Chemical Name |
CAS |
MF |
 |
Cefotiam Impurity B |
|
|
 |
pranoprofen impurity 11 |
52549-44-7 |
C15H13NO4 |
 |
Cefazolin Impurity 5 |
|
|
 |
Peramivir Impurity E |
|
|
 |
Lincomycin sulfoxide Impurity 3 |
|
|
 |
Lincomycin sulfoxide Impurity F |
|
|
 |
Fasudil iMpurity F |
|
|
![1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride](/CAS/20200401/GIF/2252446-70-9.gif) |
1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
2252446-70-9 |
C22H27ClFN3O4 |
 |
Doxofylline iMpurity E |
|
|
 |
Mupirocin Impurity 3 |
|
C26H44O9 |
 |
3,4-DICHLOROBENZYLAMINE HYDROCHLORIDE |
49552-34-3 |
C7H8Cl3N |
 |
(S)-3-メチル-1-(2-ピペリジン-1-イルフェニル)ブチルアミン |
147769-93-5 |
C16H26N2 |
 |
ジフェノキノン |
494-72-4 |
C12H8O2 |
 |
S-(+)-O-DESMETHYL VENLAFAXINE |
142761-12-4 |
C16H25NO2 |
 |
シンバスタチンアセアート |
145576-25-6 |
C27H40O6 |
 |
5-(4'-メチル-2-ビフェニル)テトラゾール |
120568-11-8 |
C14H12N4 |
 |
(2S)-2-アミノブチルアミド |
7324-11-0 |
C4H10N2O |
 |
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
![Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-](/CAS/20150408/GIF/145591-80-6.gif) |
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- |
145591-80-6 |
C11H11NO3 |
![3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)](/CAS/20150408/GIF/477600-76-3.gif) |
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) |
477600-76-3 |
C15H21N5O |
 |
MeropeneM iMpurity |
96035-23-3 |
C15H19N3O5S |
 |
デスフルオロシプロフロキサシン |
93107-11-0 |
C17H19N3O3 |
 |
Valdecoxib IMpurity-E |
1373038-63-1 |
C16H11Cl2NO5S2 |
 |
Sunitinib N-Oxide |
356068-99-0 |
C22H27FN4O3 |
 |
BendaMustine IMpurity D BendaMustine N-Alkylated IMpurity |
|
|
 |
Cefradine IMpurity E |
|
|
 |
Cetirizine IMpurity-7 |
|
C21H25ClN2O3 |
 |
Dasatinib IMpurity 6 |
|
|
 |
Desacetyl CefathiaMidine |
958001-61-1 |
C17H26N4O5S2 |
 |
Fluconazole IMpurity D |
|
C13H12F2N6O |
 |
Lercanidipine IMpurity A |
74936-74-6 |
C19H22N2O6 |
 |
Procaterol Impurity 4 |
63235-39-2 |
C16H20N2O3 |
 |
Sitagliptin Impurity 14 |
2072867-07-1 |
C26H23F9N6O2 |
 |
SofosBuvir Impurity 31 |
|
|
 |
sofosBuvir Impurity 37 |
|
|
 |
SofosBuvir Impurity 53 |
1015255-46-5 |
C20H25FN3O9P |
 |
Sofosbuvir Impurity 60 |
|
|
 |
Tenofovir impurity G |
|
|
 |
Ceftriaxone Sodium impurity 3 |
|
|
 |
Sugammadex sodium Monoiodo Impurity |
|
|
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20200401/GIF/CB85422885.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
 |
176760-99-9 |
176760-99-9 |
C17H13FN2O4 |
 |
NILOTINIB IMPURITY 17 |
851137-91-2 |
C17H15N5O |
 |
DexMedetoMidine IMpurity 16 |
|
|
 |
Canagliflozin Impurity 2 |
2952941-15-8 |
C18H14FIS |
 |
Rivaroxaban Impurity 22 |
|
|
 |
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
 |
Ezetimibe Impurity 33 |
|
|
 |
Ezetimibe-28 |
1478663-95-4 |
C44H52F2N2O6Si |
 |
Vonoprazan Impurity U4 |
|
|
 |
Emtricitabine Impurity 28 |
1238210-14-4 |
C8H11N3O4S |
 |
Parecoxib SodiuM iMpurity 37 |
|
|
![(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound](/CAS/20200611/GIF/105834-21-7.gif) |
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound |
105834-21-7 |
C20H22FNO3 |
 |
Cabozantinib Impurity 46 |
1247859-37-5 |
C11H10FNO3 |
 |
Ticagrelor Impurity 26 |
2245167-79-5 |
C21H24F2N6O3S |
 |
Vildagliptin Impurity 19 |
243145-00-8 |
C10H16N2O2 |
 |
Olopatadine Isopropyl ester Hydrochloride |
1206456-44-1 |
C24H29NO3 |
 |
GLATIRAMER impurity |
|
|
 |
Oxacillin Sodium Impurity I(EP) |
|
|
 |
Spectinomycin Impurity E |
|
|
 |
3-butyl-3-hydroxy-2-benzofuran-1-one |
162050-42-2 |
C12H14O3 |
 |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (minocycline) |
|
|
![(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione](/CAS/20180527/GIF/2088771-61-1.gif) |
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione |
2088771-61-1 |
C16H13F6N5O2 |
![N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180629/GIF/1092578-45-4.gif) |
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
1092578-45-4 |
C20H25N5 |
 |
846023-56-1 |
846023-56-1 |
C26H31Cl2N5O4 |
 |
Prednisone impurity D (EP) |
10184-69-7 |
C21H26O4 |
 |
Lisinopril EP Impurity G |
1356839-89-8 |
C42H60N6O9 |
 |
2-hexanoylbenzoic acid |
857538-11-5 |
C13H16O3 |
 |
Blonanserin N-Oxide |
142838-82-2 |
C23H30FN3O |
 |
Levofloxacin Impurity 11 |
106939-42-8 |
C9H9F2NO |
 |
Rabeprazole Impurity 2 |
1807988-36-8 |
C18H19N3O4 |
 |
Tenofovir Related Compound 14 |
1244022-52-3 |
C8H11N5O |
 |
N-(2-methyl-5-nitrophenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide |
|
C18H15N5O3 |
 |
N-(5-(benzyl(methyl)amino)-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide |
|
C25H23N5O |
![1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid](/CAS/20180527/GIF/956011-26-0.gif) |
1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid |
956011-26-0 |
C14H10FN3O2 |
 |
Nicorandil Impurity 4 Dinitrate |
1798026-96-6 |
C16H17N5O5 |
 |
WIXOVOWSUCEDGS-UHFFFAOYSA-N |
1346603-05-1 |
C15H20O5 |
 |
YXSRVOWUJUXDLJ-UHFFFAOYSA-N |
1618107-97-3 |
C18H18FNO2S |
 |
S-2-Benzothiazolyl-2-amino-±-(methoxyimino)-4-thiazolethiolacetate |
1684396-27-7 |
C13H10N4O2S3 |
 |
4-((TERT-ブチルトキシカルボニル)アミノ)シクロペント-2-エンカルボン酸(1S,4R)-メチル |
168683-02-1 |
C12H19NO4 |
 |
KNKJEUNXMFFFDU-LZHIOSKDSA-N |
138804-88-3 |
C25H34O6 |
 |
MONO-DESACETYL FAMCICLOVIR |
104227-88-5 |
C12H17N5O3 |
 |
(E)-5-(2-カルボキシビニル)-2'-デオキシウリジン |
74131-06-9 |
C12H14N2O7 |
 |
5-Decyano 5-(Ethyl Formate) Milrinone |
80442-07-5 |
C14H14N2O3 |
 |
デアセチルリファンピン |
16783-99-6 |
C41H56N4O11 |
 |
ETHYL 2-CYCLOHEXYL-2-HYDROXY-PHENYLACETATE |
31197-69-0 |
C16H22O3 |
 |
1-(4-メトキシフェニル)-2-メチル-2-プロパノール |
35144-39-9 |
C11H16O2 |
 |
1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane |
414858-02-9 |
C46H84N12 |
![butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/CAS/20180629/GIF/CB23956193.gif) |
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate |
2227199-31-5 |
C20H29N5O3 |
 |
ethyl 2-((E)-5-((E)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetate |
682775-71-9 |
C17H17NO3S2 |
 |
(4-ヒドロキシ-2-メチル-2H-1,2-ベンゾチアジン-3-カルボン酸エチル)1,1-ジオキシド |
24683-26-9 |
C12H13NO5S |
 |
Sugammadex |
1378831-29-8 |
C6H10O3S2 |
 |
1-(2,3-ジヒドロ-1,4-ベンゾジオキサン-2-カルボニル)ピペラジン塩酸塩 |
70918-74-0 |
C13H17ClN2O3 |
![[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenyl] 4-chlorobenzoate](/CAS/20180719/GIF/41859-56-7.gif) |
[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenyl] 4-chlorobenzoate |
41859-56-7 |
C22H17Cl2NO3 |
 |
N-(2,4-ジクロロ-5-ヒドロキシフェニル)アセトアミド |
67669-19-6 |
C8H7Cl2NO2 |
 |
2-(クロロメチル)-3-メチル-4-(2,2,2-トリフルオロエトキシ)ピリジン |
128430-66-0 |
C9H9ClF3NO |
 |
2-メチル-5-ニトロ-1-(オキシラン-2-イルメチル)-1H-イミダゾール |
16773-52-7 |
C7H9N3O3 |
 |
Bendamustine Related Impurity 12 |
|
|
 |
Bendamustine Related Impurity 3 |
|
|
 |
Edoxaban Impurity 26 (1R,2S,4R) |
1255529-33-9 |
C21H30ClN5O5 |